1.
Silverberg JI, Kragh N, Guttman-Yassky E, Wollenberg A. Treatment with tralokinumab improves health-related quality of life in adult patients with moderate to severe atopic dermatitis: results from a Phase 2b, randomised, double-blind, placebo-controlled study. J of Skin [Internet]. 2018Dec.17 [cited 2023Jan.26];2:S64. Available from: https://www.jofskin.org/index.php/skin/article/view/460